Physician profile
John E Coletta
NPI 1609997071
$127,939.91
in general payments reported to CMS, 2019-2025
29 companies · $3,200 in 2025
The $3,200 reported for 2025 was more than what 76% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60K · 2020: $3,547 · 2021: $16K · 2022: $22K · 2023: $5,317 · 2024: $18K · 2025: $3,200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $19K · Food and Beverage: $4,815 · Travel and Lodging: $2,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $19,045.00 |
| Food and Beverage | $4,814.89 |
| Travel and Lodging | $2,659.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $120,360.22 | 2019-2024 | Xarelto |
| Abbott Laboratories | $4,134.85 | 2020-2025 | Optis, Dragonfly Opstar, Diamondback Coronary |
| Medtronic, INC. | $637.57 | 2021-2025 | Onyx Frontier, Symplicity G3, Euphora |
| Novartis Pharmaceuticals Corporation | $572.24 | 2019-2025 | |
| Shockwave Medical, INC | $481.11 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Astrazeneca Pharmaceuticals LP | $280.38 | 2019-2025 | Farxiga, Wainua |
| Vifor Pharma, INC. | $173.49 | 2019-2020 | |
| Boston Scientific Corporation | $165.52 | 2022-2025 | General - Atherectomy, Watchman Flx, Ranger |
| Boehringer Ingelheim Pharmaceuticals, INC. | $156.30 | 2019-2025 | Jardiance |
| Esperion Therapeutics, INC. | $152.85 | 2025 | Nexletol |
| E.R. Squibb & Sons, L.L.C. | $116.47 | 2019-2025 | Camzyos |
| Amgen INC. | $113.67 | 2019-2025 | Repatha |
| Medtronic Vascular, INC. | $81.52 | 2019-2020 | |
| Ge Healthcare | $78.78 | 2023 | |
| Amarin Pharma, INC. | $74.44 | 2019-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $56.96 | 2023 | |
| Pfizer INC. | $47.06 | 2019-2020 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $41.69 | 2023-2024 | Lifevest |
| Abiomed | $40.13 | 2024-2025 | Impella |
| Irhythm Technologies, INC. | $27.96 | 2024 | Zio Monitor, Zio Xt Patch |
| Bolton Medical INC | $23.56 | 2019 | |
| Chiesi USA, INC. | $19.34 | 2023 | Kengreal, Cleviprex |
| Actelion Pharmaceuticals US, INC. | $17.45 | 2024 | Opsumit |
| Kestra Medical Technology Services, INC. | $16.71 | 2023 | Assure Wcd |
| Merck Sharp & Dohme LLC | $16.09 | 2023 | Verquvo |
| Ekos Corporation | $14.76 | 2019 | |
| Terumo Medical Corporation | $14.34 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $12.45 | 2019 | |
| Cardinal Health 200 LLC | $12.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Coletta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.